Molecular Weight:   | 165.08 |
Volume:   | 173.695 |
LogP:   | -1.507 |
LogD:   | 0.406 |
LogS:   | -1.627 |
# Rotatable Bonds:   | 3 |
TPSA:   | 63.32 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 3 |
# Rings:   | 1 |
# Heavy Atoms:   | 3 |
QED Drug-Likeness Score:   | 0.69 |
Synthetic Accessibility Score:   | 1.882 |
Fsp3:   | 0.222 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Rejected |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -5.579 |
MDCK Permeability:   | 0.001067422330379486 |
Pgp-inhibitor:   | 0.0 |
Pgp-substrate:   | 0.159 |
Human Intestinal Absorption (HIA):   | 0.016 |
20% Bioavailability (F20%):   | 0.001 |
30% Bioavailability (F30%):   | 0.0 |
Blood-Brain-Barrier Penetration (BBB):   | 0.524 |
Plasma Protein Binding (PPB):   | 31.094249725341797% |
Volume Distribution (VD):   | 0.42 |
Pgp-substrate:   | 69.74173736572266% |
CYP1A2-inhibitor:   | 0.062 |
CYP1A2-substrate:   | 0.049 |
CYP2C19-inhibitor:   | 0.043 |
CYP2C19-substrate:   | 0.09 |
CYP2C9-inhibitor:   | 0.005 |
CYP2C9-substrate:   | 0.169 |
CYP2D6-inhibitor:   | 0.154 |
CYP2D6-substrate:   | 0.322 |
CYP3A4-inhibitor:   | 0.013 |
CYP3A4-substrate:   | 0.099 |
Clearance (CL):   | 13.104 |
Half-life (T1/2):   | 0.763 |
hERG Blockers:   | 0.093 |
Human Hepatotoxicity (H-HT):   | 0.193 |
Drug-inuced Liver Injury (DILI):   | 0.017 |
AMES Toxicity:   | 0.015 |
Rat Oral Acute Toxicity:   | 0.693 |
Maximum Recommended Daily Dose:   | 0.014 |
Skin Sensitization:   | 0.257 |
Carcinogencity:   | 0.05 |
Eye Corrosion:   | 0.014 |
Eye Irritation:   | 0.127 |
Respiratory Toxicity:   | 0.331 |
Natural Product ID:   | NPC10781 |
Common Name*:   | L-Phenylalanine |
IUPAC Name:   | (2S)-2-azaniumyl-3-phenylpropanoate |
Synonyms:   | L-Phenylalanine; Phenylalanine |
Standard InCHIKey:   | COLNVLDHVKWLRT-QMMMGPOBSA-N |
Standard InCHI:   | InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1 |
SMILES:   | c1ccc(cc1)C[C@@H](C(=O)O)N |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL301523 |
PubChem CID:   |
6925665 6140 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPO11043 | NPC10781 | n.a. | n.a. | 289 | n.a. | n.a. | mg/100g of FW |
PMID[18460139] |
NPO163 | NPC10781 | n.a. | n.a. | 31 | n.a. | n.a. | mg/100g of FW |
PMID[18460139] |
NPO26643 | NPC10781 | n.a. | n.a. | 78 | n.a. | n.a. | mg/100g of FW |
PMID[18460139] |
NPO7530 | NPC10781 | n.a. | n.a. | 19 | n.a. | n.a. | mg/100g of FW |
PMID[18460139] |
NPO7576.2 | NPC10781 | n.a. | n.a. | 172 | n.a. | n.a. | mg/100g of FW |
PMID[18460139] |
NPO7576.2 | NPC10781 | n.a. | n.a. | 49 | n.a. | n.a. | mg/100g of FW |
PMID[18460139] |
NPO21556 | NPC10781 | n.a. | Sclerotia | 0.076 ± 0.021 | n.a. | n.a. | % |
PMID[20527951] |
NPO13281 | NPC10781 | n.a. | Seeds | 1.6 | n.a. | n.a. | % | DOI[10.5219/332] |
NPO13281 | NPC10781 | n.a. | Seeds | 1.02 | n.a. | n.a. | % |
PMID[31159190] |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Activity | = | 210.0 | % | PMID[525345] |
NPT1062 | Individual Protein | Carbonic anhydrase IV | Homo sapiens | KA | = | 4.6 | uM | PMID[525347] |
NPT1142 | Individual Protein | Voltage-gated calcium channel alpha2/delta subunit 1 | Mus musculus | Ki | = | 980.0 | nM | PMID[525348] |
NPT1142 | Individual Protein | Voltage-gated calcium channel alpha2/delta subunit 1 | Mus musculus | Ki | = | 977.24 | nM | PMID[525348] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525349] |
NPT1061 | Individual Protein | Carbonic anhydrase XIII | Mus musculus | KA | = | 1.02 | uM | PMID[525349] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525350] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Kcat | = | 5.7 | 10^6/s | PMID[525350] |
NPT1143 | Individual Protein | Carbonic anhydrase VA | Homo sapiens | KA | = | 9.81 | uM | PMID[525351] |
NPT1144 | Individual Protein | Carbonic anhydrase VB | Homo sapiens | KA | = | 10.45 | uM | PMID[525351] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ka | = | 0.013 | uM | PMID[525352] |
NPT1063 | Individual Protein | Carbonic anhydrase VI | Homo sapiens | Ka | = | 1.23 | uM | PMID[525352] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Kcat | = | 5.7 | 10^6/s | PMID[525352] |
NPT1063 | Individual Protein | Carbonic anhydrase VI | Homo sapiens | Kcat | = | 10.3 | 10^5/s | PMID[525352] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Kcat | = | 5.7 | 10^6/s | PMID[525353] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525353] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ka | = | 0.013 | uM | PMID[525355] |
NPT1145 | Individual Protein | Carbonic anhydrase | Saccharomyces cerevisiae S288c | Ka | = | 86.0 | uM | PMID[525355] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ka | = | 0.013 | uM | PMID[525356] |
NPT1146 | Individual Protein | Carbonic anhydrase III | Homo sapiens | Ka | = | 34.7 | uM | PMID[525356] |
NPT1062 | Individual Protein | Carbonic anhydrase IV | Homo sapiens | Ka | = | 36.3 | uM | PMID[525356] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525357] |
NPT1146 | Individual Protein | Carbonic anhydrase III | Homo sapiens | KA | = | 34.7 | uM | PMID[525357] |
NPT1062 | Individual Protein | Carbonic anhydrase IV | Homo sapiens | KA | = | 36.3 | uM | PMID[525358] |
NPT1147 | Individual Protein | Carbonic anhydrase 15 | Mus musculus | KA | = | 33.4 | uM | PMID[525358] |
NPT3157 | Individual Protein | Carbonic anhydrase 2 | Cryptococcus neoformans var. grubii | KA | = | 44.1 | uM | PMID[525359] |
NPT1148 | Individual Protein | Carbonic anhydrase | Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) | KA | = | 15.5 | uM | PMID[525359] |
NPT1149 | Individual Protein | Phospholipase A-2-activating protein | Homo sapiens | IC50 | > | 5000.0 | nM | PMID[525360] |
NPT1063 | Individual Protein | Carbonic anhydrase VI | Homo sapiens | KA | = | 1.23 | uM | PMID[525361] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525361] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ka | = | 0.013 | uM | PMID[525362] |
NPT1150 | Individual Protein | Carbonic anhydrase | Methanobacterium thermoautotrophicum | Ka | = | 70.0 | uM | PMID[525362] |
NPT1145 | Individual Protein | Carbonic anhydrase | Saccharomyces cerevisiae S288c | Ka | = | 86.0 | uM | PMID[525362] |
NPT1151 | Individual Protein | Carbonic anhydrase | Candida glabrata CBS 138 | Ka | = | 24.1 | uM | PMID[525362] |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | logPapp | = | -4.63 | n.a. | PMID[525363] |
NPT1152 | Individual Protein | L-type amino acid transporter 1 | Rattus norvegicus | Ki | = | 55000.0 | nM | PMID[525364] |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Potency | n.a. | 11220.2 | nM | PMID[525367] |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | n.a. | 15.8 | nM | PMID[525367] |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | n.a. | 15848.9 | nM | PMID[525367] |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | n.a. | 4547.9 | nM | PMID[525366] |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | n.a. | 28695.4 | nM | PMID[525366] |
NPT1153 | Individual Protein | Monocarboxylate transporter 10 | Rattus norvegicus | Activity | = | 40.0 | % | PMID[525368] |
NPT1153 | Individual Protein | Monocarboxylate transporter 10 | Rattus norvegicus | Activity | = | 50.0 | % | PMID[525368] |
NPT1104 | Individual Protein | SLC16A10 protein | Homo sapiens | Activity | = | 60.0 | % | PMID[525369] |
NPT1153 | Individual Protein | Monocarboxylate transporter 10 | Rattus norvegicus | Km | = | 7020000.0 | nM | PMID[525368] |
NPT1104 | Individual Protein | SLC16A10 protein | Homo sapiens | Km | = | 740500.0 | nM | PMID[525370] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 54482.7 | nM | PMID[525372] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Kcat | = | 5.7 | 10'6/s | PMID[525373] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525373] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Activity | = | 80.0 | % | PMID[525375] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525377] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 21689.9 | nM | PMID[525372] |
NPT1156 | Individual Protein | Intestinal alkaline phosphatase | Bos taurus | IC50 | = | 80210.0 | nM | PMID[525380] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Inhibition | = | 85.0 | % | PMID[525382] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Activity | = | 3.6 | fmol/min | PMID[525382] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525383] |
NPT4793 | Individual Protein | Carbonic anhydrase | Methanosarcina thermophila | KA | = | 68.0 | uM | PMID[525383] |
NPT1156 | Individual Protein | Intestinal alkaline phosphatase | Bos taurus | IC50 | = | 80210.0 | nM | PMID[525384] |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | KA | = | 0.013 | uM | PMID[525387] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | IC50 | = | 69000.0 | nM | PMID[525388] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Km | = | 11000.0 | nM | PMID[525388] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Inhibition | = | 85.0 | % | PMID[525388] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Activity | = | 100.0 | % | PMID[525388] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Km | = | 14200.0 | nM | PMID[525388] |
NPT4309 | Individual Protein | Inhibitor of apoptosis protein 3 | Homo sapiens | IC50 | = | 80200.0 | nM | PMID[525391] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Inhibition | = | 85.0 | % | PMID[525392] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | IC50 | = | 69000.0 | nM | PMID[525392] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Activity | = | 2.7 | fmol/min | PMID[525392] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Activity | = | 3.6 | fmol/min | PMID[525398] |
NPT1157 | Individual Protein | L-type amino acid transporter 1 | Homo sapiens | Inhibition | = | 85.0 | % | PMID[525398] |
NPT27 | Others | Unspecified | Solubility ratio | = | 1.036 | n.a. | PMID[525338] | |
NPT27 | Others | Unspecified | Solubility ratio | = | 1.048 | n.a. | PMID[525338] | |
NPT27 | Others | Unspecified | Solubility ratio | = | 1.093 | n.a. | PMID[525338] | |
NPT27 | Others | Unspecified | Solubility ratio | = | 1.178 | n.a. | PMID[525338] | |
NPT27 | Others | Unspecified | Solubility | = | 245000.0 | ug.mL-1 | PMID[525338] | |
NPT27 | Others | Unspecified | Solubility | = | 173200.0 | ug.mL-1 | PMID[525338] | |
NPT605 | Organism | Homo sapiens | Homo sapiens | T1/2 | = | 29.0 | hr | PMID[525339] |
NPT605 | Organism | Homo sapiens | Homo sapiens | T1/2 | = | 0.003333 | hr | PMID[525339] |
NPT2 | Others | Unspecified | Log 1/T | = | 2.19 | n.a. | PMID[525341] | |
NPT35 | Others | n.a. | LogP | = | 1.49 | n.a. | PMID[525341] | |
NPT2 | Others | Unspecified | Ratio | = | 1.036 | n.a. | PMID[525342] | |
NPT2 | Others | Unspecified | Ratio | = | 1.048 | n.a. | PMID[525342] | |
NPT2 | Others | Unspecified | Ratio | = | 1.093 | n.a. | PMID[525342] | |
NPT2 | Others | Unspecified | Ratio | = | 1.178 | n.a. | PMID[525342] | |
NPT2 | Others | Unspecified | Concentration | = | 24.5 | g dl-1 | PMID[525342] | |
NPT2 | Others | Unspecified | Control value | = | 17.32 | g dl-1 | PMID[525342] | |
NPT2 | Others | Unspecified | Ratio | = | 1.175 | n.a. | PMID[525342] | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Permeability | = | 3.57 | n.a. | PMID[525343] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 1.036 | n.a. | PMID[525344] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 1.048 | n.a. | PMID[525344] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 1.093 | n.a. | PMID[525344] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 1.178 | n.a. | PMID[525344] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Activity | = | 160.0 | % | PMID[525345] |
NPT35 | Others | n.a. | Solubility | = | 1.036 | n.a. | PMID[525346] | |
NPT35 | Others | n.a. | Solubility | = | 1.048 | n.a. | PMID[525346] | |
NPT35 | Others | n.a. | Solubility | = | 1.093 | n.a. | PMID[525346] | |
NPT35 | Others | n.a. | Solubility | = | 1.178 | n.a. | PMID[525346] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525349] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525350] |
NPT955 | Individual Protein | Carbonic anhydrase VII | Homo sapiens | KA | = | 10.93 | uM | PMID[525350] |
NPT954 | Individual Protein | Carbonic anhydrase XIV | Homo sapiens | KA | = | 0.24 | uM | PMID[525350] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Kcat | = | 19.8 | 10^5/s | PMID[525350] |
NPT955 | Individual Protein | Carbonic anhydrase VII | Homo sapiens | Kcat | = | 14.6 | 10^5/s | PMID[525350] |
NPT954 | Individual Protein | Carbonic anhydrase XIV | Homo sapiens | Kcat | = | 12.5 | 10^5/s | PMID[525350] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ka | = | 0.07 | uM | PMID[525352] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Kcat | = | 19.8 | 10^5/s | PMID[525352] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Kcat | = | 19.8 | 10^5/s | PMID[525353] |
NPT948 | Individual Protein | Carbonic anhydrase IX | Homo sapiens | Kcat | = | 4.7 | 10^5/s | PMID[525353] |
NPT949 | Individual Protein | Carbonic anhydrase XII | Homo sapiens | Kcat | = | 12.4 | 10^5/s | PMID[525353] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525353] |
NPT948 | Individual Protein | Carbonic anhydrase IX | Homo sapiens | KA | = | 16.3 | uM | PMID[525353] |
NPT949 | Individual Protein | Carbonic anhydrase XII | Homo sapiens | KA | = | 1.38 | uM | PMID[525353] |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Activity | = | -1.0 | % | PMID[525354] |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Activity | = | -2.0 | % | PMID[525354] |
NPT2 | Others | Unspecified | Ka | = | 70.0 | uM | PMID[525355] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ka | = | 0.07 | uM | PMID[525356] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525357] |
NPT2 | Others | Unspecified | KA | = | 70.0 | uM | PMID[525357] | |
NPT2 | Others | Unspecified | KA | = | 68.0 | uM | PMID[525357] | |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | IC50 | > | 5000.0 | nM | PMID[525360] |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | > | 5000.0 | nM | PMID[525360] |
NPT2 | Others | Unspecified | KA | = | 34.0 | uM | PMID[525361] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525361] |
NPT35 | Others | n.a. | Daq | = | 9.8 | 10'-6cm2/s | PMID[525363] | |
NPT35 | Others | n.a. | LogP | = | -1.38 | n.a. | PMID[525363] | |
NPT605 | Organism | Homo sapiens | Homo sapiens | F | = | 100.0 | % | PMID[525363] |
NPT27 | Others | Unspecified | permeability | = | 3.36 | 10'-4 cm/s | PMID[525363] | |
NPT35 | Others | n.a. | pKa | = | 2.2 | n.a. | PMID[525363] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2393.4 | nM | PMID[525366] |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Kcat | = | 19.8 | 10'5/s | PMID[525373] |
NPT2 | Others | Unspecified | Kcat | = | 1.4 | 10'7/s | PMID[525373] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525373] |
NPT2 | Others | Unspecified | KA | = | 0.008 | uM | PMID[525373] | |
NPT23991 | MACROMOLECULE | Lipopolysaccharide (LPS) | Bacteria | Inhibition | = | 80.0 | % | PMID[525375] |
NPT27 | Others | Unspecified | Activity | = | 70.0 | % | PMID[525375] | |
NPT23991 | MACROMOLECULE | Lipopolysaccharide (LPS) | Bacteria | Inhibition | = | 54.0 | % | PMID[525375] |
NPT23991 | MACROMOLECULE | Lipopolysaccharide (LPS) | Bacteria | Inhibition | = | 32.0 | % | PMID[525375] |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | = | 25000.0 | nM | PMID[525375] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 25000.0 | nM | PMID[525375] |
NPT17 | Organism | Staphylococcus epidermidis | Staphylococcus epidermidis | MIC | = | 13200.0 | nM | PMID[525375] |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | = | 11300.0 | nM | PMID[525375] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 6250.0 | nM | PMID[525375] |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | MIC | = | 6100.0 | nM | PMID[525375] |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | MIC | = | 6000.0 | nM | PMID[525375] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 6000.0 | nM | PMID[525375] |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 3100.0 | nM | PMID[525375] |
NPT87 | Organism | Aspergillus fumigatus | Aspergillus fumigatus | MIC | = | 3000.0 | nM | PMID[525375] |
NPT330 | Organism | Trichophyton mentagrophytes | Trichophyton mentagrophytes | MIC | = | 3000.0 | nM | PMID[525375] |
NPT1155 | Organism | Sporothrix schenckii | Sporothrix schenckii | MIC | = | 3000.0 | nM | PMID[525375] |
NPT188 | Organism | Candida parapsilosis | Candida parapsilosis | MIC | = | 3000.0 | nM | PMID[525375] |
NPT2 | Others | Unspecified | KA | = | 0.062 | uM | PMID[525377] | |
NPT2 | Others | Unspecified | KA | = | 0.008 | uM | PMID[525377] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525377] |
NPT35 | Others | n.a. | pKa | n.a. | 2.2 | n.a. | PMID[525378] | |
NPT35 | Others | n.a. | pKa | n.a. | 9.08 | n.a. | PMID[525378] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1000.0 | nM | PMID[525379] | |
NPT2 | Others | Unspecified | KA | = | 34.1 | uM | PMID[525381] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525383] |
NPT2 | Others | Unspecified | KA | = | 1.73 | uM | PMID[525383] | |
NPT2 | Others | Unspecified | Kcat | = | 9.82 | 10'5/s | PMID[525383] | |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | IC50 | = | 100100.0 | nM | PMID[525385] |
NPT35 | Others | n.a. | Activity | = | 0.0025 | umolequiv/umol | PMID[525386] | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | KA | = | 0.07 | uM | PMID[525387] |
NPT2 | Others | Unspecified | KA | = | 9.16 | uM | PMID[525387] | |
NPT21652 | SINGLE PROTEIN | Carbonic anhydrase-like protein, putative | Trypanosoma cruzi (strain CL Brener) | KA | = | 12.1 | uM | PMID[525387] |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | = | 80200.0 | nM | PMID[525389] |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | IC50 | > | 200000.0 | nM | PMID[525390] |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | = | 100000.0 | nM | PMID[525390] |
NPT2 | Others | Unspecified | Ratio IC50 | > | 2.0 | n.a. | PMID[525390] | |
NPT21075 | SINGLE PROTEIN | Cholesterol 24-hydroxylase | Homo sapiens | Activity | = | 90.0 | % | PMID[525393] |
NPT22587 | SINGLE PROTEIN | Taste receptor type 2 member 39 | Homo sapiens | Inhibition | = | 0.0 | % | PMID[525394] |
NPT2 | Others | Unspecified | IC50 | = | 80210.0 | nM | PMID[525396] | |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[525397] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[525397] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC10781 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC293628 |
1.0 | High Similarity | NPC122493 |
0.978 | High Similarity | NPC324569 |
0.9278 | High Similarity | NPC67043 |
0.9271 | High Similarity | NPC164859 |
0.8958 | High Similarity | NPC12730 |
0.8824 | High Similarity | NPC319579 |
0.88 | High Similarity | NPC327481 |
0.8738 | High Similarity | NPC329011 |
0.8654 | High Similarity | NPC474584 |
0.8469 | Intermediate Similarity | NPC322598 |
0.8411 | Intermediate Similarity | NPC197470 |
0.8333 | Intermediate Similarity | NPC106551 |
0.8333 | Intermediate Similarity | NPC281686 |
0.8333 | Intermediate Similarity | NPC188867 |
0.8222 | Intermediate Similarity | NPC127343 |
0.8113 | Intermediate Similarity | NPC313981 |
0.8108 | Intermediate Similarity | NPC239697 |
0.8018 | Intermediate Similarity | NPC142638 |
0.8018 | Intermediate Similarity | NPC317784 |
0.7981 | Intermediate Similarity | NPC476198 |
0.7965 | Intermediate Similarity | NPC326079 |
0.7959 | Intermediate Similarity | NPC323164 |
0.7957 | Intermediate Similarity | NPC285773 |
0.7957 | Intermediate Similarity | NPC44830 |
0.7917 | Intermediate Similarity | NPC325441 |
0.7879 | Intermediate Similarity | NPC291070 |
0.7879 | Intermediate Similarity | NPC246757 |
0.7857 | Intermediate Similarity | NPC314992 |
0.7838 | Intermediate Similarity | NPC2265 |
0.7826 | Intermediate Similarity | NPC35996 |
0.7789 | Intermediate Similarity | NPC95965 |
0.7755 | Intermediate Similarity | NPC258627 |
0.7739 | Intermediate Similarity | NPC27581 |
0.7629 | Intermediate Similarity | NPC322387 |
0.7627 | Intermediate Similarity | NPC477937 |
0.7611 | Intermediate Similarity | NPC169328 |
0.7573 | Intermediate Similarity | NPC164514 |
0.7573 | Intermediate Similarity | NPC108606 |
0.7573 | Intermediate Similarity | NPC290515 |
0.7573 | Intermediate Similarity | NPC303611 |
0.7573 | Intermediate Similarity | NPC226096 |
0.7563 | Intermediate Similarity | NPC58827 |
0.7563 | Intermediate Similarity | NPC307437 |
0.7563 | Intermediate Similarity | NPC72473 |
0.7551 | Intermediate Similarity | NPC329064 |
0.7544 | Intermediate Similarity | NPC310467 |
0.75 | Intermediate Similarity | NPC16031 |
0.75 | Intermediate Similarity | NPC161593 |
0.75 | Intermediate Similarity | NPC145888 |
0.75 | Intermediate Similarity | NPC226438 |
0.7478 | Intermediate Similarity | NPC319950 |
0.7453 | Intermediate Similarity | NPC471317 |
0.7451 | Intermediate Similarity | NPC215351 |
0.7451 | Intermediate Similarity | NPC20142 |
0.7438 | Intermediate Similarity | NPC325651 |
0.7414 | Intermediate Similarity | NPC190663 |
0.7414 | Intermediate Similarity | NPC80150 |
0.74 | Intermediate Similarity | NPC70940 |
0.74 | Intermediate Similarity | NPC274455 |
0.74 | Intermediate Similarity | NPC86670 |
0.7396 | Intermediate Similarity | NPC288903 |
0.7363 | Intermediate Similarity | NPC122327 |
0.7363 | Intermediate Similarity | NPC113000 |
0.7363 | Intermediate Similarity | NPC112609 |
0.7327 | Intermediate Similarity | NPC317645 |
0.7317 | Intermediate Similarity | NPC48909 |
0.7288 | Intermediate Similarity | NPC142577 |
0.7288 | Intermediate Similarity | NPC160493 |
0.7282 | Intermediate Similarity | NPC161972 |
0.7282 | Intermediate Similarity | NPC303045 |
0.7265 | Intermediate Similarity | NPC478015 |
0.7265 | Intermediate Similarity | NPC478014 |
0.7265 | Intermediate Similarity | NPC478016 |
0.7258 | Intermediate Similarity | NPC88667 |
0.7257 | Intermediate Similarity | NPC35850 |
0.7257 | Intermediate Similarity | NPC276949 |
0.7245 | Intermediate Similarity | NPC294134 |
0.7241 | Intermediate Similarity | NPC237420 |
0.7228 | Intermediate Similarity | NPC316108 |
0.7222 | Intermediate Similarity | NPC229235 |
0.7222 | Intermediate Similarity | NPC150254 |
0.7222 | Intermediate Similarity | NPC147000 |
0.7222 | Intermediate Similarity | NPC304761 |
0.7222 | Intermediate Similarity | NPC226778 |
0.7212 | Intermediate Similarity | NPC25565 |
0.7212 | Intermediate Similarity | NPC3371 |
0.7203 | Intermediate Similarity | NPC56634 |
0.7203 | Intermediate Similarity | NPC71684 |
0.7193 | Intermediate Similarity | NPC33742 |
0.7157 | Intermediate Similarity | NPC110704 |
0.7157 | Intermediate Similarity | NPC86987 |
0.7143 | Intermediate Similarity | NPC475439 |
0.7143 | Intermediate Similarity | NPC473501 |
0.7143 | Intermediate Similarity | NPC314835 |
0.7143 | Intermediate Similarity | NPC311242 |
0.7143 | Intermediate Similarity | NPC155429 |
0.7128 | Intermediate Similarity | NPC290638 |
0.7128 | Intermediate Similarity | NPC325662 |
0.7128 | Intermediate Similarity | NPC98269 |
0.7115 | Intermediate Similarity | NPC172925 |
0.7107 | Intermediate Similarity | NPC4974 |
0.7107 | Intermediate Similarity | NPC47667 |
0.7091 | Intermediate Similarity | NPC274089 |
0.7091 | Intermediate Similarity | NPC191215 |
0.7083 | Intermediate Similarity | NPC309279 |
0.7083 | Intermediate Similarity | NPC192623 |
0.704 | Intermediate Similarity | NPC326966 |
0.7037 | Intermediate Similarity | NPC327226 |
0.7037 | Intermediate Similarity | NPC318154 |
0.7031 | Intermediate Similarity | NPC132636 |
0.703 | Intermediate Similarity | NPC477704 |
0.703 | Intermediate Similarity | NPC477693 |
0.7025 | Intermediate Similarity | NPC222466 |
0.6992 | Remote Similarity | NPC199738 |
0.6992 | Remote Similarity | NPC321561 |
0.6992 | Remote Similarity | NPC210950 |
0.6992 | Remote Similarity | NPC476353 |
0.6981 | Remote Similarity | NPC477767 |
0.6972 | Remote Similarity | NPC202613 |
0.6967 | Remote Similarity | NPC101719 |
0.6961 | Remote Similarity | NPC470877 |
0.6961 | Remote Similarity | NPC9822 |
0.6939 | Remote Similarity | NPC323103 |
0.6935 | Remote Similarity | NPC311753 |
0.6935 | Remote Similarity | NPC296712 |
0.6931 | Remote Similarity | NPC471638 |
0.6923 | Remote Similarity | NPC282087 |
0.6923 | Remote Similarity | NPC14672 |
0.6923 | Remote Similarity | NPC259800 |
0.6923 | Remote Similarity | NPC318028 |
0.6923 | Remote Similarity | NPC328137 |
0.6923 | Remote Similarity | NPC318984 |
0.6923 | Remote Similarity | NPC285926 |
0.6923 | Remote Similarity | NPC241086 |
0.6923 | Remote Similarity | NPC315276 |
0.6923 | Remote Similarity | NPC317741 |
0.6916 | Remote Similarity | NPC229242 |
0.6916 | Remote Similarity | NPC160548 |
0.6916 | Remote Similarity | NPC271475 |
0.6916 | Remote Similarity | NPC175852 |
0.6916 | Remote Similarity | NPC210529 |
0.6915 | Remote Similarity | NPC276699 |
0.6907 | Remote Similarity | NPC121800 |
0.6903 | Remote Similarity | NPC158854 |
0.6899 | Remote Similarity | NPC287358 |
0.6893 | Remote Similarity | NPC78041 |
0.6893 | Remote Similarity | NPC62765 |
0.6893 | Remote Similarity | NPC141139 |
0.6893 | Remote Similarity | NPC209764 |
0.6893 | Remote Similarity | NPC121872 |
0.6893 | Remote Similarity | NPC471307 |
0.6893 | Remote Similarity | NPC84288 |
0.6893 | Remote Similarity | NPC74936 |
0.6893 | Remote Similarity | NPC159178 |
0.688 | Remote Similarity | NPC478147 |
0.687 | Remote Similarity | NPC57976 |
0.6869 | Remote Similarity | NPC270507 |
0.6864 | Remote Similarity | NPC470545 |
0.686 | Remote Similarity | NPC84281 |
0.686 | Remote Similarity | NPC317474 |
0.686 | Remote Similarity | NPC291027 |
0.686 | Remote Similarity | NPC169485 |
0.686 | Remote Similarity | NPC213126 |
0.6852 | Remote Similarity | NPC125732 |
0.6852 | Remote Similarity | NPC217621 |
0.6852 | Remote Similarity | NPC245561 |
0.6842 | Remote Similarity | NPC139658 |
0.6838 | Remote Similarity | NPC188010 |
0.6833 | Remote Similarity | NPC45777 |
0.6833 | Remote Similarity | NPC477061 |
0.6829 | Remote Similarity | NPC474847 |
0.6827 | Remote Similarity | NPC141607 |
0.6827 | Remote Similarity | NPC187725 |
0.6822 | Remote Similarity | NPC472788 |
0.6822 | Remote Similarity | NPC253423 |
0.6818 | Remote Similarity | NPC68055 |
0.6818 | Remote Similarity | NPC66518 |
0.6807 | Remote Similarity | NPC470546 |
0.6807 | Remote Similarity | NPC229353 |
0.6804 | Remote Similarity | NPC170484 |
0.68 | Remote Similarity | NPC111428 |
0.6794 | Remote Similarity | NPC326860 |
0.6794 | Remote Similarity | NPC197239 |
0.6792 | Remote Similarity | NPC58674 |
0.6789 | Remote Similarity | NPC52472 |
0.6789 | Remote Similarity | NPC214200 |
0.6789 | Remote Similarity | NPC136810 |
0.6789 | Remote Similarity | NPC128248 |
0.6789 | Remote Similarity | NPC133809 |
0.6789 | Remote Similarity | NPC264728 |
0.6789 | Remote Similarity | NPC228400 |
0.6789 | Remote Similarity | NPC225079 |
0.6789 | Remote Similarity | NPC94487 |
0.678 | Remote Similarity | NPC470544 |
0.6774 | Remote Similarity | NPC208302 |
0.6774 | Remote Similarity | NPC74458 |
0.6772 | Remote Similarity | NPC45191 |
0.6772 | Remote Similarity | NPC246913 |
0.6768 | Remote Similarity | NPC103387 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC10781 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD9566 | Approved |
0.9053 | High Similarity | NPD253 | Approved |
0.8411 | Intermediate Similarity | NPD1348 | Approved |
0.8333 | Intermediate Similarity | NPD9568 | Approved |
0.8318 | Intermediate Similarity | NPD747 | Discontinued |
0.8155 | Intermediate Similarity | NPD1040 | Phase 2 |
0.8132 | Intermediate Similarity | NPD226 | Approved |
0.8113 | Intermediate Similarity | NPD3643 | Approved |
0.8113 | Intermediate Similarity | NPD3642 | Approved |
0.8113 | Intermediate Similarity | NPD189 | Phase 3 |
0.8113 | Intermediate Similarity | NPD3644 | Approved |
0.8113 | Intermediate Similarity | NPD188 | Approved |
0.8108 | Intermediate Similarity | NPD4504 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD5162 | Approved |
0.7965 | Intermediate Similarity | NPD3881 | Discontinued |
0.7957 | Intermediate Similarity | NPD9491 | Approved |
0.7857 | Intermediate Similarity | NPD2217 | Approved |
0.7857 | Intermediate Similarity | NPD2218 | Phase 2 |
0.7826 | Intermediate Similarity | NPD3880 | Clinical (unspecified phase) |
0.7802 | Intermediate Similarity | NPD225 | Approved |
0.7802 | Intermediate Similarity | NPD227 | Approved |
0.7778 | Intermediate Similarity | NPD1812 | Approved |
0.7778 | Intermediate Similarity | NPD1814 | Approved |
0.7748 | Intermediate Similarity | NPD255 | Approved |
0.7748 | Intermediate Similarity | NPD256 | Approved |
0.7739 | Intermediate Similarity | NPD4761 | Approved |
0.7739 | Intermediate Similarity | NPD4762 | Approved |
0.7739 | Intermediate Similarity | NPD4706 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD1374 | Approved |
0.7727 | Intermediate Similarity | NPD1371 | Approved |
0.7727 | Intermediate Similarity | NPD1370 | Approved |
0.7727 | Intermediate Similarity | NPD1373 | Approved |
0.7706 | Intermediate Similarity | NPD9508 | Approved |
0.7692 | Intermediate Similarity | NPD196 | Phase 1 |
0.7672 | Intermediate Similarity | NPD3073 | Approved |
0.7672 | Intermediate Similarity | NPD3071 | Approved |
0.7672 | Intermediate Similarity | NPD3072 | Approved |
0.7652 | Intermediate Similarity | NPD2956 | Clinical (unspecified phase) |
0.7629 | Intermediate Similarity | NPD4793 | Discontinued |
0.7607 | Intermediate Similarity | NPD4677 | Discontinued |
0.7607 | Intermediate Similarity | NPD182 | Clinical (unspecified phase) |
0.7573 | Intermediate Similarity | NPD9609 | Approved |
0.7573 | Intermediate Similarity | NPD9612 | Approved |
0.7573 | Intermediate Similarity | NPD9611 | Approved |
0.7527 | Intermediate Similarity | NPD9490 | Approved |
0.75 | Intermediate Similarity | NPD9569 | Approved |
0.75 | Intermediate Similarity | NPD7828 | Discontinued |
0.7475 | Intermediate Similarity | NPD800 | Approved |
0.7475 | Intermediate Similarity | NPD5346 | Phase 2 |
0.7475 | Intermediate Similarity | NPD5347 | Phase 2 |
0.7431 | Intermediate Similarity | NPD476 | Approved |
0.7417 | Intermediate Similarity | NPD4151 | Approved |
0.74 | Intermediate Similarity | NPD1090 | Approved |
0.74 | Intermediate Similarity | NPD1086 | Approved |
0.74 | Intermediate Similarity | NPD1089 | Approved |
0.7377 | Intermediate Similarity | NPD1070 | Approved |
0.7377 | Intermediate Similarity | NPD1069 | Approved |
0.7363 | Intermediate Similarity | NPD9593 | Approved |
0.7363 | Intermediate Similarity | NPD9589 | Approved |
0.7363 | Intermediate Similarity | NPD9592 | Approved |
0.7363 | Intermediate Similarity | NPD9588 | Approved |
0.7363 | Intermediate Similarity | NPD9594 | Approved |
0.7363 | Intermediate Similarity | NPD80 | Approved |
0.7363 | Intermediate Similarity | NPD9591 | Approved |
0.7363 | Intermediate Similarity | NPD9590 | Approved |
0.7355 | Intermediate Similarity | NPD3040 | Approved |
0.7355 | Intermediate Similarity | NPD4177 | Approved |
0.7355 | Intermediate Similarity | NPD4175 | Approved |
0.7353 | Intermediate Similarity | NPD1066 | Discontinued |
0.7333 | Intermediate Similarity | NPD6302 | Clinical (unspecified phase) |
0.7327 | Intermediate Similarity | NPD1239 | Approved |
0.7317 | Intermediate Similarity | NPD5581 | Approved |
0.7315 | Intermediate Similarity | NPD999 | Phase 2 |
0.7295 | Intermediate Similarity | NPD4676 | Approved |
0.7295 | Intermediate Similarity | NPD5263 | Approved |
0.7258 | Intermediate Similarity | NPD259 | Phase 1 |
0.7255 | Intermediate Similarity | NPD1088 | Approved |
0.725 | Intermediate Similarity | NPD5367 | Discontinued |
0.7241 | Intermediate Similarity | NPD6093 | Discontinued |
0.7236 | Intermediate Similarity | NPD9718 | Approved |
0.7236 | Intermediate Similarity | NPD9536 | Phase 1 |
0.7236 | Intermediate Similarity | NPD9537 | Phase 1 |
0.7222 | Intermediate Similarity | NPD315 | Approved |
0.7222 | Intermediate Similarity | NPD309 | Approved |
0.7222 | Intermediate Similarity | NPD314 | Approved |
0.7222 | Intermediate Similarity | NPD310 | Approved |
0.7222 | Intermediate Similarity | NPD311 | Approved |
0.7222 | Intermediate Similarity | NPD10 | Approved |
0.719 | Intermediate Similarity | NPD3606 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD3719 | Approved |
0.7184 | Intermediate Similarity | NPD5122 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD3718 | Approved |
0.7179 | Intermediate Similarity | NPD5981 | Approved |
0.7168 | Intermediate Similarity | NPD181 | Approved |
0.7168 | Intermediate Similarity | NPD2607 | Approved |
0.7143 | Intermediate Similarity | NPD555 | Phase 2 |
0.7115 | Intermediate Similarity | NPD688 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD1693 | Approved |
0.7105 | Intermediate Similarity | NPD3598 | Phase 3 |
0.71 | Intermediate Similarity | NPD1087 | Approved |
0.7097 | Intermediate Similarity | NPD3136 | Phase 2 |
0.7091 | Intermediate Similarity | NPD467 | Phase 1 |
0.7087 | Intermediate Similarity | NPD6690 | Approved |
0.7064 | Intermediate Similarity | NPD9610 | Approved |
0.7064 | Intermediate Similarity | NPD9608 | Approved |
0.7063 | Intermediate Similarity | NPD4153 | Approved |
0.7063 | Intermediate Similarity | NPD6623 | Phase 3 |
0.7063 | Intermediate Similarity | NPD5296 | Approved |
0.7053 | Intermediate Similarity | NPD9564 | Approved |
0.7053 | Intermediate Similarity | NPD296 | Approved |
0.7053 | Intermediate Similarity | NPD9563 | Approved |
0.7053 | Intermediate Similarity | NPD295 | Approved |
0.7053 | Intermediate Similarity | NPD293 | Approved |
0.7053 | Intermediate Similarity | NPD79 | Approved |
0.7048 | Intermediate Similarity | NPD5206 | Clinical (unspecified phase) |
0.704 | Intermediate Similarity | NPD5299 | Approved |
0.7031 | Intermediate Similarity | NPD1536 | Approved |
0.7031 | Intermediate Similarity | NPD6852 | Discontinued |
0.7031 | Intermediate Similarity | NPD6295 | Approved |
0.7031 | Intermediate Similarity | NPD6294 | Approved |
0.7009 | Intermediate Similarity | NPD1067 | Discontinued |
0.7009 | Intermediate Similarity | NPD9712 | Approved |
0.7 | Intermediate Similarity | NPD1018 | Approved |
0.6992 | Remote Similarity | NPD257 | Approved |
0.6992 | Remote Similarity | NPD258 | Approved |
0.6981 | Remote Similarity | NPD1099 | Approved |
0.6981 | Remote Similarity | NPD1566 | Phase 3 |
0.6981 | Remote Similarity | NPD1100 | Approved |
0.6981 | Remote Similarity | NPD1564 | Approved |
0.6981 | Remote Similarity | NPD1565 | Approved |
0.6977 | Remote Similarity | NPD6864 | Phase 2 |
0.6977 | Remote Similarity | NPD6865 | Phase 2 |
0.6957 | Remote Similarity | NPD2652 | Approved |
0.6957 | Remote Similarity | NPD2650 | Approved |
0.6953 | Remote Similarity | NPD3528 | Clinical (unspecified phase) |
0.6953 | Remote Similarity | NPD6073 | Approved |
0.6953 | Remote Similarity | NPD5725 | Approved |
0.6949 | Remote Similarity | NPD4479 | Discontinued |
0.6944 | Remote Similarity | NPD4760 | Clinical (unspecified phase) |
0.6942 | Remote Similarity | NPD2584 | Suspended |
0.6942 | Remote Similarity | NPD5108 | Clinical (unspecified phase) |
0.6929 | Remote Similarity | NPD5323 | Approved |
0.6923 | Remote Similarity | NPD1537 | Approved |
0.6923 | Remote Similarity | NPD9570 | Approved |
0.6923 | Remote Similarity | NPD1538 | Phase 1 |
0.6923 | Remote Similarity | NPD1519 | Approved |
0.6916 | Remote Similarity | NPD9711 | Approved |
0.6916 | Remote Similarity | NPD9710 | Approved |
0.6916 | Remote Similarity | NPD9495 | Approved |
0.6903 | Remote Similarity | NPD1756 | Approved |
0.6903 | Remote Similarity | NPD1752 | Approved |
0.6899 | Remote Similarity | NPD4126 | Approved |
0.6899 | Remote Similarity | NPD1520 | Approved |
0.6899 | Remote Similarity | NPD1521 | Approved |
0.6893 | Remote Similarity | NPD3673 | Approved |
0.6893 | Remote Similarity | NPD9256 | Approved |
0.6893 | Remote Similarity | NPD3672 | Approved |
0.6893 | Remote Similarity | NPD9258 | Approved |
0.688 | Remote Similarity | NPD6359 | Clinical (unspecified phase) |
0.688 | Remote Similarity | NPD4125 | Approved |
0.688 | Remote Similarity | NPD1974 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD1071 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD3908 | Approved |
0.6864 | Remote Similarity | NPD1758 | Phase 1 |
0.686 | Remote Similarity | NPD4216 | Approved |
0.686 | Remote Similarity | NPD3132 | Approved |
0.686 | Remote Similarity | NPD4218 | Approved |
0.686 | Remote Similarity | NPD2611 | Approved |
0.686 | Remote Similarity | NPD2612 | Approved |
0.686 | Remote Similarity | NPD2609 | Approved |
0.686 | Remote Similarity | NPD3131 | Approved |
0.686 | Remote Similarity | NPD4215 | Approved |
0.686 | Remote Similarity | NPD4217 | Approved |
0.686 | Remote Similarity | NPD2608 | Approved |
0.686 | Remote Similarity | NPD2610 | Approved |
0.6855 | Remote Similarity | NPD5339 | Clinical (unspecified phase) |
0.6855 | Remote Similarity | NPD3608 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD2066 | Phase 3 |
0.6852 | Remote Similarity | NPD3097 | Clinical (unspecified phase) |
0.6838 | Remote Similarity | NPD7508 | Discontinued |
0.6829 | Remote Similarity | NPD2198 | Approved |
0.6829 | Remote Similarity | NPD2199 | Approved |
0.6825 | Remote Similarity | NPD4794 | Discontinued |
0.6825 | Remote Similarity | NPD4738 | Phase 2 |
0.6825 | Remote Similarity | NPD6919 | Clinical (unspecified phase) |
0.6822 | Remote Similarity | NPD528 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD168 | Phase 1 |
0.6818 | Remote Similarity | NPD167 | Phase 2 |
0.681 | Remote Similarity | NPD1681 | Approved |
0.681 | Remote Similarity | NPD1680 | Approved |
0.681 | Remote Similarity | NPD1682 | Approved |
0.6807 | Remote Similarity | NPD1759 | Phase 1 |
0.6803 | Remote Similarity | NPD1360 | Approved |
0.6803 | Remote Similarity | NPD1077 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD5759 | Approved |
0.6794 | Remote Similarity | NPD1522 | Approved |
0.6794 | Remote Similarity | NPD1523 | Approved |
0.678 | Remote Similarity | NPD732 | Approved |
0.678 | Remote Similarity | NPD733 | Approved |
0.6774 | Remote Similarity | NPD292 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.